{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:06:56Z","timestamp":1747163216138,"version":"3.40.5"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaapos.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jaapos.2024.103970","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T06:24:52Z","timestamp":1720938292000},"page":"103970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paradoxical keratitis and dermatitis following adalimumab treatment"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7005-9613","authenticated-orcid":false,"given":"Noor","family":"Ghali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif O.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2024.103970_bib1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrgastro.2012.125","article-title":"Paradoxical inflammation induced by anti-TNF agents in patients with IBD","volume":"9","author":"Cleynen","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jaapos.2024.103970_bib2","first-page":"88","article-title":"Paradoxical reactions to biologicals in chronic inflammatory systemic diseases","volume":"119","author":"Kremenevski","year":"2022","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jaapos.2024.103970_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/14740338.4.4.637","article-title":"Adalimumab: a review of side effects","volume":"4","author":"Scheinfeld","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaapos.2024.103970_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.959575","article-title":"Chronic recurrent multifocal osteomyelitis: a narrative and pictorial review","volume":"13","author":"Sergi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaapos.2024.103970_bib5","article-title":"Chronic recurrent multifocal osteomyelitis: a comprehensive literature review","volume":"15","author":"Hassan","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jaapos.2024.103970_bib6","first-page":"43","article-title":"Chronic recurrent multifocal osteomyelitis causing optic neuropathy","volume":"26","author":"Mudri","year":"2022","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.jaapos.2024.103970_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215739","article-title":"Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: an example of a proposed trial of adalimumab versus pamidronate for children with CNO\/CRMO","volume":"14","author":"Ramanan","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaapos.2024.103970_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s11914-017-0405-9","article-title":"Chronic recurrent multifocal osteomyelitis (CRMO): presentation, pathogenesis, and treatment","volume":"15","author":"Hofmann","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jaapos.2024.103970_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cxo.12904","article-title":"Ocular complications of tumour necrosis factor alpha inhibitors","volume":"103","author":"Kowalski","year":"2020","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.jaapos.2024.103970_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12886-015-0047-6","article-title":"Systemic adalimumab induces peripheral corneal infiltrates: a case report","volume":"15","author":"Matet","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jaapos.2024.103970_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.survophthal.2023.10.002","article-title":"Ocular surface toxicities associated with modern anticancer therapies","volume":"69","author":"Boucher","year":"2024","journal-title":"Surv Ophthalmol"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853124002507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853124002507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T23:50:12Z","timestamp":1731455412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853124002507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1091853124002507"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2024.103970","relation":{},"ISSN":["1091-8531"],"issn-type":[{"type":"print","value":"1091-8531"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical keratitis and dermatitis following adalimumab treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2024.103970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Association for Pediatric Ophthalmology and Strabismus.","name":"copyright","label":"Copyright"}],"article-number":"103970"}}